IL-2 gene transcription is affected by several nuclear proteins. We asked whether dexamethasone (Dex) and cyclosporin A (CsA) inhibit IL-2 gene transcription by interfering with the activity of nuclear proteins that bind to the IL-2 promoter. Nuclear extracts from primary human T lymphocytes were analyzed by electrophoretic DNA mobility shift assays. Both Dex and CsA inhibited the binding oftranscription factors AP-1 and NF-AT, but not of NF-kB and OCT-1 /OAF, to their corresponding sites on the IL-2 gene promoter. To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections. Jurkat cells were transfected with plasmids containing either the intact IL-2 promoter or its AP-1, NF-AT, and NF-kB motifs. Dex inhibited the IL-2 promoter and the AP-1, but not the NF-AT and NF-kB plasmids. In contrast, CsA inhibited the IL-2 promoter and the NF-AT, but not the AP-1 and NF-kB plasmids. These results suggest that in human T lymphocytes both Dex and CsA inhibited IL-2 gene transcription through interference with transcription factors AP-1 and NF-AT. We propose that, while maximum inhibition may involve interaction with both transcription factors, AP-1 is the primary target of Dex. (J. Clin.
Introduction
Glucocorticoids (GC) I have assumed a major role in the treatment of allograft rejection, autoimmune, allergic, and malignant diseases. Their widespread use is based on their profound effects on inflammatory and immune responses. GC affect the growth, differentiation, and function of monocytes and lymphocytes, the distribution ofcellular subsets, and cytokine pro-duction ( 1) . In spite oftheir widespread medical use, the mechanism of their inhibitory effects has not been completely defined.
We have recently reported that dexamethasone (Dex), a synthetic GC hormone, inhibits the nuclear transcription of IL-2 gene in primary human T lymphocytes (2) . IL-2 gene transcription is mediated by a region extending -326 bp upstream ofthe transcription start site. This promoter region contains binding sites for at least seven nuclear proteins ( Fig. 1; references [3] [4] [5] [6] [7] [8] [9] . Analysis ofthe IL-2 promoter has not revealed any cis-reacting sequences (glucocorticoid response elements, GRE) for binding of the activated GC receptor and negative transcriptional regulation ( 10) . Thus, delineation ofthe mechanism of negative transcriptional regulation of IL-2 promoter has been the subject of active investigation over the last two years. Even though several recent publications have explored this area in transformed human or mouse lymphocytes (11, 12) , the mechanisms of GC-mediated inhibition of IL-2 gene transcription in primary human T lymphocytes remain unknown.
Using electrophoretic DNA mobility shift assays (EMSA) and transient DNA transfection assays, we have examined whether interference with activity of nuclear proteins binding to IL-2 promoter may explain the inhibitory effects of GC on IL-2 nuclear transcription. To better understand the effect of GC on primary human T lymphocytes, we have also examined their effect on transiently transfected transformed T lymphocytes with reporter constructs containing specific IL-2 promoter motifs and have compared it with the effect of another unrelated inhibitor of IL-2 gene transcription, cyclosporin A (CsA) (13) (14) (15) (16) (17) . Our data suggest that in primary human T lymphocytes GC and CsA inhibit IL-2 gene transcription by interfering with transcription factors AP-l and NF-AT. Our data also suggest that while AP-1 is the primary target for GCmediated repression of IL-2 gene transcription, NF-AT appears to be the main target of CsA action. CATassay. CAT assay was carried out as described previously (25) by incubation of Stimulation through ionomycin and PMA induces the activity ofnuclear proteins AT, NF-kB, AP-I and OCT/OAP, all ofwhich are thought to contribute to the transcriptional activation of IL-2 promoter in various degrees (7, 9, 26, 27) . Recent data have suggested a functional antagonism between the AP-1 transcriptional factor for the collagenase gene and the activated GR (28) (29) (30) . We therefore first examined the effect of Dex on the activity of the AP-l site of the human IL-2 promoter.
Binding of nuclear proteins from stimulated primary human T lymphocytes to the AP-J site of the IL-2 promoter is inhibited by Dex (34) . The human IL-2 promoter contains two TREs, one proximal and one distal. Footprint and deletion analysis has shown that only proximal TRE binds strongly AP-1 and has revealed its importance in IL-2 enhancer activity (7-9). Human peripheral blood T lymphocytes were therefore stimulated with ionomycin and PMA after preincubation with Dex (> 8 h) or CsA (0.5 h). Nuclear extracts were isolated 16 h later and analyzed in an EMSA using end-labeled DNA fragment corresponding to the proximal AP-l site of the IL-2 enhancer. In agreement with previous observations (21 ), unstimulated T lymphocytes contain little or no AP-1 activity (Fig. 3 A) . Stimulation of these cells effectively induced AP-1 activity. The sequence specificity of the binding was assessed by using molar excess of homologous and heterologous oligonucleotide as competitors. Protein binding to the 32P-labeled IL-2 AP-I site was inhibited by a cold homologous, but not with a heterologous (NF-kB) oligonucleotide (see Methods). An antibody raised against a peptide common to the DNA-binding region of Jun proteins, but not an equivalent concentration of normal rabbit immunoglobulin, specifically blocked protein binding, suggesting that it contains Jun protein and identifying it as the AP-I factor (Fig. 3 B ). An antibody raised against c-fos decreased the mobility of this complex, suggesting that it contains c-fos protein. Both Dex and CsA inhibited the formation of the AP-1 complex. Lower concentration of Dex (l0-7 M) had little effect (Fig. 3 A) , whereas 10-8 M had no effect (not shown). These results suggest that both Dex and CsA inhibit the binding of the AP-1 transcription factor to the AP-1 site of the human IL-2 promoter. (Fig. 4) . In contrast to Dex, CsA failed to suppress the activity of this construct. As expected, when cells were stimulated with ionomycin and PMA, activity of AP-1 CAT was induced by severalfold. Dex inhibited the inducible activity ofAP-1 CAT by a mean of -70% (range 60-80%) at 10-6 M and 30% (range 35-25%) at 10-7 M, when cells were harvested at 18 h. Similar results were obtained when cells were harvested at 8-and 36-h time points (not shown). Lower doses ofDex ( o0-8 M) did not have a significant effect on AP-1 CAT activity (not shown). In contrast to Dex, CsA failed to inhibit the inducible activity of AP-1 CAT (Fig. 5) at concentrations that were previously found to be effective for downregulation of IL-2 promoter activity. Concentrations of CsA as high as 1 ,ug/ml were not effective (not shown). Taken together, these results confirm the in vitro data for inhibition of AP-1 by Dex and suggest that this inhibition does not require the presence of other motifs ofthe IL-2 promoter. The discrepancy between the in vitro and the in vivo data observed when CsA was used may be due to the difference in cell types (primary vs. transformed). These data are in agreement with previous reports suggesting that in Jurkat cells AP-1 activity by EMSA or transfection assays is not inhibited by CsA ( 14, 15, 17) . Inhibition of AP-1 activity in vitro by CsA in primary human T lymphocytes (by EMSA) has also been reported by Granelli-Piperno et al. ( 16) .
NF-AT activity in primary human T lymphocytes is inhibited by Dex or CsA. In contrast to nuclear factor AP-1, which is ubiquitous, NF-AT has been found only in lymphoid cells (27) . Unstimulated primary human T lymphocytes contain no detectable activity for NF-AT as determined by EMSA. In stimulated T lymphocytes NF-AT activity appears within 6 h after stimulation and continues to increase until it reaches a peak within -36 h (21 ). Induction of NF-AT in transformed human T lymphocytes requires two activation-dependent effects: a CsA-sensitive translocation ofa preexisting cytoplasmic component to the nucleus and a CsA-resistant synthesis of a nuclear component (35) . Recent data in murine T lymphocytes suggest that the CsA-insensitive nuclear component is AP-l (which is added to the preexisting NF-AT complex) and that there is close physical and functional interaction (crosstalk) between AP-1 and NF-AT (36) . We therefore examined the effect of Dex on NF-AT activity. Primary human T lymphocytes were stimulated by ionomycin and PMA in the presence of Dex or CsA. Nuclear extracts were isolated 18 and 36 h later and analyzed by EMSA using a radiolabeled oligonucleotide probe for the AT site of the human IL-2 promoter. Unstimulated cells did not exhibit any AT activity (Fig. 5) . Stimulation of cells resulted in induction of AT activity, which was inhibited by both Dex or CsA at 36 h (Fig. 5 ). Analysis at 8 and 18 h revealed similar results. Binding of nuclear proteins was sequence specific, as demonstrated by competition assays with related and unrelated (NF-kB) DNA (Fig. 5) . Inhibition of NF-AT activity by CsA in primary human T lymphocytes corroborates previous findings in both primary and transformed T lymphocytes ( 14-16).
CsA but not Dex inhibits the transcriptional activity of a transfectedplasmid containing the AT site in Jurkat cells. NF-AT activity is inhibited by Dex in vitro. We examined these phenomena in vivo by transfection assays. Jurkat cells were transiently transfected with pNF-AT CAT, which contains three copies of the NF-AT site of the human IL-2 promoter linked to the CAT gene (5) . Plasmids containing a single copy of the NF-AT site are not inducible (5, 11, 12) . As shown in Fig. 6 , unstimulated Jurkat cells did not exhibit any detectable CAT activity. Neither Dex nor CsA affected the baseline activity of this plasmid (Fig. 6) . Activation of Jurkat cells led to a dramatic induction of pNF-AT CAT. Dex at 10-6 or 10-7 M did not affect the activity ofthis plasmid (Fig. 6) . Harvesting of (Fig. 7) . When higher concentrations of Dex were used (10-' M) in DNA transfection assays with pNF-AT, CAT results were identical (not shown). Taken together, these results suggest that the NF-AT site, by itself, is not sufficient for GC mediated inhibition. Given the highly cooperative interaction among the various transcription factors for the IL-2 gene promoter (27) , it is possible that additional sites are required in order that NF-AT may confer susceptibility to GC (see Discussion). Neither Dex nor CsA inhibits the activity ofnuclearproteins binding to the OCT-I site ofthe human IL-2 promoter. OCT-1 is a ubiquitous octamer binding nuclear protein that participates in the induction of IL-2 promoter activity by interacting with both DNA and a 40-kD protein called OCT-I -associated protein (OAP) (37) . Two octamer-binding sites are identified in the human IL-2 promoter, one proximal and one distal (Fig.  1) . Protein extracts of stimulated primary T lymphocytes bind very poorly to the OCT-I distal site (21 ) . In contrast, binding to the proximal OCT-1 is strong. Levels of OCT-I activity are low in unstimulated T cells and are induced after stimulation reaching a peak at -6 h (21 ). As shown in Fig. 8 , unstimulated primary T lymphocytes exhibited low levels of OCT-1 binding activity that were not affected by pretreatment by Dex or CsA (not shown). Two bands are apparent in this figure, one upper and one lower. Competition with related cold oligonucleotide (OCT-I) completely inhibited the binding of the label in the upper band, whereas it competed less effectively for binding in the lower band. Competition with a heterologous (NF-kB) oligonucleotide did not exhibit any demonstrable effect on binding of these proteins. This suggests that upper band is specific for OCT-1, whereas binding to the lower band represents nonspecific binding. Both Dex or CsA failed to inhibit the activity of OCT-1/OAP nuclear proteins.
NF-kB activity is not inhibited by Dex or CsA. NF-kB is involved in the inducible transcription of several genes coding for cytokines or their receptors (27, (38) (39) (40) (41) . In contrast to IL- 2Ra gene, where NF-kB is essential for transcription, its relative importance for IL-2 promoter activity is not well established (5, 7, 27) . In unstimulated human T lymphocytes low to undetectable levels of NF-kB activity are present by EMSA. Stimulation of T lymphocytes leads to a rapid induction of NF-kB activity, which peaks within 6 h and persists at similar levels for 2 36 hours (21 ). As depicted in Fig. 9 , unstimulated T lymphocytes expressed low levels ofactivity for the kB site of the IL-2 promoter by EMSA. Dex increased approximately NF-xcB were analyzed by EMSA as described in Fig. 3 .
A DNA probe (-206 (36) . Our work raises the possibility that the primary target of GC in mediating inhibition of IL-2 promoter activity is transcriptional factor AP-1, whereas its effect on NF-AT activity maybe, at least in part, indirect, through decreasing AP-l activity.
A functional antagonism that involves direct protein to protein interactions between AP-l and GR has been reported by several investigators (28) (29) (30) (12) , who suggest that inhibition of IL-2 transcription by GC is mediated by direct interaction between GR and a factor that binds to two sequences located in the proximal half of the IL-2 promoter (NKIL2B/AP-1 and NFIL2A/OCT-l/OAP). These sequences bind a similar, if not identical, inducible nuclear factor that has biological characteristics that distinguish it from AP-l (likelyOAP) (12 ) . The discrepancy ofthese results may be due to differences in cell types used (primary or transformed human vs. transformed human or murine) or to differences in experimental protocols.
To our knowledge this is the first demonstration of GC 
